Follow
Mark M. Davis
Mark M. Davis
Verified email at stanford.edu
Title
Cited by
Cited by
Year
Phenotypic analysis of antigen-specific T lymphocytes
JD Altman, PAH Moss, PJR Goulder, DH Barouch, ...
Science 274 (5284), 94-96, 1996
47431996
T-cell antigen receptor genes and T-cell recognition
MM Davis, PJ Bjorkman
Nature 334 (6181), 395-402, 1988
43701988
The immunological synapse: a molecular machine controlling T cell activation
A Grakoui, SK Bromley, C Sumen, MM Davis, AS Shaw, PM Allen, ...
Science 285 (5425), 221-227, 1999
41101999
Isolation of cDNA clones encoding T cell-specific membrane-associated proteins
SM Hedrick, DI Cohen, EA Nielsen, MM Davis
Nature 308 (5955), 149-153, 1984
17111984
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
L Fong, Y Hou, A Rivas, C Benike, A Yuen, GA Fisher, MM Davis, ...
Proceedings of the National Academy of Sciences 98 (15), 8809-8814, 2001
15002001
miR-181a is an intrinsic modulator of T cell sensitivity and selection
QJ Li, J Chau, PJR Ebert, G Sylvester, H Min, G Liu, R Braich, ...
Cell 129 (1), 147-161, 2007
14722007
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
PP Lee, C Yee, PA Savage, L Fong, D Brockstedt, JS Weber, D Johnson, ...
Nature medicine 5 (6), 677-685, 1999
13791999
The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.
RA Seder, WE Paul, MM Davis, B Fazekas de St Groth
The Journal of experimental medicine 176 (4), 1091-1098, 1992
13221992
Ligand recognition by αβ T cell receptors
MM Davis, JJ Boniface, Z Reich, D Lyons, J Hampl, B Arden, Y Chien
Annual review of immunology 16 (1), 523-544, 1998
13021998
The immunological synapse
SK Bromley, WR Burack, KG Johnson, K Somersalo, TN Sims, C Sumen, ...
Annual review of immunology 19 (1), 375-396, 2001
12442001
Clonal replacement of tumor-specific T cells following PD-1 blockade
KE Yost, AT Satpathy, DK Wells, Y Qi, C Wang, R Kageyama, ...
Nature medicine 25 (8), 1251-1259, 2019
12212019
Organoid modeling of the tumor immune microenvironment
JT Neal, X Li, J Zhu, V Giangarra, CL Grzeskowiak, J Ju, IH Liu, SH Chiou, ...
Cell 175 (7), 1972-1988. e16, 2018
12002018
An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH
P Early, H Huang, M Davis, K Calame, L Hood
Cell 19 (4), 981-992, 1980
11771980
Variation in the human immune system is largely driven by non-heritable influences
P Brodin, V Jojic, T Gao, S Bhattacharya, CJL Angel, D Furman, ...
Cell 160 (1), 37-47, 2015
11022015
Two mRNAs can be produced from a single immunoglobulin μ gene by alternative RNA processing pathways
P Early, J Rogers, M Davis, K Calame, M Bond, R Wall, L Hood
Cell 20 (2), 313-319, 1980
10921980
Diversity in the CDR3 region of VH is sufficient for most antibody specificities
JL Xu, MM Davis
Immunity 13 (1), 37-45, 2000
10882000
Direct observation of ligand recognition by T cells
DJ Irvine, MA Purbhoo, M Krogsgaard, MM Davis
Nature 419 (6909), 845-849, 2002
10412002
Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells
CA Turner Jr, DH Mack, MM Davis
Cell 77 (2), 297-306, 1994
10221994
Identifying specificity groups in the T cell receptor repertoire
J Glanville, H Huang, A Nau, O Hatton, LE Wagar, F Rubelt, X Ji, A Han, ...
Nature 547 (7661), 94-98, 2017
9582017
Multiple early factors anticipate post-acute COVID-19 sequelae
Y Su, D Yuan, DG Chen, RH Ng, K Wang, J Choi, S Li, S Hong, R Zhang, ...
Cell 185 (5), 881-895. e20, 2022
9432022
The system can't perform the operation now. Try again later.
Articles 1–20